Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04724291 · ClinicalTrials.gov registry record · NA
MAGNET (Magnetically Controlled Capsule for Assessment of Gastric Mucosa in Symptomatic Patients)
A NA study, sponsored by George Washington University.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
NCT04724291 is a NA study that has completed, run by George Washington University. The registered enrollment target is 43 participants.
The verdict
NCT04724291, a NA study, has completed, sponsored by George Washington University.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
Study Summary
This pilot and feasibility study will be first US study to determine if a magnetically controlled capsule (MCC) can effectively visualize the anatomy of the stomach like a more traditional upper endoscopy (EGD). This study is designed to enroll participants who have a standard indication for an EGD and are also willing to get an MCC exam. The MCC is driven actively by a clinician unlike prior capsule endoscopes that move passively by gravity or peristalsis. Thus, a physician will be able to look more closely at areas of the stomach that might be concerning and might need further evaluation and/or treatment.
Interventions
- DEVICE MAGNET
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2021-02-10 |
| Est. Completion | 2023-06-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04724291
The ClinicalTrials.gov registry entry for NCT04724291 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is George Washington University, which has 133 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MAGNET is the first listed.
NCT04724291 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04724291 about?
NCT04724291 is a clinical study titled "MAGNET (Magnetically Controlled Capsule for Assessment of Gastric Mucosa in Symptomatic Patients)". This pilot and feasibility study will be first US study to determine if a magnetically controlled capsule (MCC) can effectively visualize the anatomy of the stomach like a more traditional upper endoscopy (EGD). This study is designed to enroll participants who have a standard indication for an EGD ...
What is the current status of trial NCT04724291?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2021-02-10. Estimated completion is 2023-06-10.
What interventions are being tested in trial NCT04724291?
The interventions under investigation include: MAGNET (DEVICE).
Who is sponsoring clinical trial NCT04724291?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.